Viewing Study NCT00654732


Ignite Creation Date: 2025-12-24 @ 9:34 PM
Ignite Modification Date: 2026-02-19 @ 8:45 AM
Study NCT ID: NCT00654732
Status: COMPLETED
Last Update Posted: 2020-02-28
First Post: 2008-04-03
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Combination Chemotherapy With or Without Rituximab in Treating Participants With Stage III-IV Classic Hodgkin Lymphoma
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Classic Hodgkin Lymphoma View
None Lugano Classification Stage III Hodgkin Lymphoma AJCC v8 View
None Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8 View
Keywords: